Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desogestrel for Preoperative Treatment of Endometrioma
NCT04941833Phase 3Completed
- Sponsor
- Ministry of Public Health
- Start
- Jun 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of desogestrel in endometrioma (2 arms), sponsored by Ministry of Public Health. Primary endpoint: Cyst diameter at 3 months. Started Jun 2021; status: completed.
02
Drugs
desogestrel
03
Conditions
endometrioma
Beyond the preview
Go deeper on NCT04941833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04941833.